Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Martha MorrellChief Medical Officer | NeuroPaceNPCE | Open-market sale | 25/12/15 | 03/04 | 25,000 sh | $15.97 | $399,250 | −33.3% |
NeuroPaceNPCE | Open-market sale | 25/05/14 | 25/05/16 | 168,136 sh2 trades | $15.85avg. | $2,665,332.88 | −4.9% | |
Martha MorrellChief Medical Officer | NeuroPaceNPCE | Open-market sale | 25/02/21 | 25/02/25 | 78,334 sh | $13.72 | $1,074,742.48 | −48.9% |
KCK10% Owner | NeuroPaceNPCE | Open-market sale | 25/02/20 | 25/02/20 | 5,270,845 sh | $9.40 | $49,545,943 | −100.0% |
NeuroPaceNPCE | Open-market sale10b5-1 plan | 25/01/29–25/01/30 | 25/01/31 | 300 sh2 trades | $15.00avg. | $4,500 | −0.3% | |
Martha MorrellChief Medical Officer | NeuroPaceNPCE | Open-market sale10b5-1 plan | 25/01/24 | 25/01/28 | 3,200 sh | $15.01 | $48,032 | −3.5% |
NeuroPaceNPCE | Open-market sale | 24/10/23–24/10/25 | 24/10/28 | 224,138 sh2 trades | $5.45avg. | $1,221,635.89 | −4.1% | |
KCK10% Owner | NeuroPaceNPCE | Open-market sale | 24/10/22 | 24/10/24 | 4,082 sh | $6.09 | $24,859.38 | −0.1% |
NeuroPaceNPCE | Open-market sale | 24/10/18–24/10/21 | 24/10/22 | 8,598 sh2 trades | $6.21avg. | $53,374.62 | −0.2% | |
NeuroPaceNPCE | Open-market sale | 24/10/03–24/10/17 | 24/10/18 | 46,426 sh11 trades | $6.54avg. | $303,445.04 | −0.8% | |
NeuroPaceNPCE | Open-market sale | 24/08/30–24/10/02 | 24/10/03 | 39,684 sh13 trades | $6.92avg. | $274,713.9 | −0.7% | |
NeuroPaceNPCE | Open-market sale | 24/05/01–24/05/03 | 24/05/03 | 29,206 sh3 trades | $14.02avg. | $409,426.44 | −0.9% | |
Orbimed Advisors10% Owner | NeuroPaceNPCE | Open-market sale | 24/04/24 | 24/04/26 | 1,781 sh | $14.06 | $25,040.86 | −0.1% |
NeuroPaceNPCE | Open-market sale | 24/04/19–24/04/23 | 24/04/23 | 64,653 sh3 trades | $14.12avg. | $913,056.9 | −1.8% | |
NeuroPaceNPCE | Open-market sale | 24/04/16–24/04/18 | 24/04/18 | 16,992 sh3 trades | $14.02avg. | $238,231.07 | −0.5% | |
NeuroPaceNPCE | Open-market sale | 24/04/11–24/04/12 | 24/04/15 | 485,000 sh2 trades | $14.49avg. | $7,026,032.93 | −12.1% | |
NeuroPaceNPCE | Open-market sale | 24/02/02–24/02/05 | 24/02/06 | 17,589 sh2 trades | $15.09avg. | $265,410.83 | −18.4% | |
NeuroPaceNPCE | Open-market sale | 24/01/30–24/02/01 | 24/02/01 | 13,848 sh3 trades | $15.09avg. | $209,026.56 | −12.7% | |
NeuroPaceNPCE | Open-market sale | 24/01/24–24/01/25 | 24/01/26 | 828 sh2 trades | $15.03avg. | $12,444.81 | −0.8% | |
NeuroPaceNPCE | Open-market sale | 23/12/26–23/12/27 | 23/12/28 | 13,402 sh2 trades | $10.12avg. | $135,616 | −10.9% |